Abstract: Condensation of 4-benzoyl-1,2-phenylenediamine with sodium pyruvate in acetic acid furnished two products which were identified as 6-benzoyl and 7-benzoyl-3-methyl-2(1H)quinoxalinones (1a,b). Fusion of 1a with aromatic aldehydes furnished the styryl derivatives 2a-c. Alkylation of 1a,b with dimethyl sulphate or ethyl chloroacetate produced the N-alkyl derivatives 3a,b and 4a,b. Hydrazinolysis of the ester derivative 4a with hydrazine hydrate afforded the hydrazide derivative 5 which underwent condensation with aldehydes to give the corresponding hydrazone derivatives 6a,b. In addition, chlorination of 1a with thionyl chloride afforded the 2-chloro derivative 7 which was subjected to reaction with sodium azide and n-butylamine to yield the corresponding tetrazolo (8) and n-butylamino (9) derivatives, respectively. The structures of the compounds prepared were confirmed by analytical and spectral data. Also, some of the synthesized compounds were screened for antimicrobial activity.
Introduction
Numerous quinoxaline derivatives are important as antibacterial, antifungal, anticancer, antidepressant and antiinflammatory agents [1] [2] [3] . From this point of view and in continuation of our interest on the chemistry of quinoxaline [4] [5] [6] [7] [8] [9] , it was of interest to synthesized some quinoxalinone derivatives with the aim of investigating their antimicrobial properties.
Results and Discussion
Condensation of 4-benzoyl-1,2-phenylenediamine with sodium pyruvate in acetic acid at room temperature furnished two products which showed analytical and spectral data in good agreement with the 3-methylquinoxalinone structures 1a,b. The reaction proceeds due to the (-R) effect of the benzoyl group which deactivates the p-amino group, thus the m-amino group initiates the reaction to give 6-benzoyl-3-methyl-2(1H)quinoxalinone 1a as the main product (60%). The second isomer was obtained in 30% yield and identified as 7-benzoyl-3-methyl-2(1H)quinoxalinone 1b (Scheme 1). The 1 H NMR spectrum of 1a in DMSO-d 6 exhibited signals at 2.6 (3H, s, CH 3 ), 8 .21 (1H, broad, NH; cancelled with D 2 O). Also, the mass spectrum displayed a molecular ion peak at m/z 264 (70%). The proposed fragmentation pattern of 1a is illustrated in Scheme 2. .
Scheme 2. Fragmentation pattern of compound 1a.
6-Benzoyl-3-substituted styryl-2(1H)quinoxalinones 2a-c were obtained via fusion of 1a with aromatic aldehydes in the presence of piperidine at 160 0 C. The 1 H NMR of 2b in DMSO-d 6 showed signals at 4.2 (3H, s, OCH 3 ), 7.20, 7.65 (2H, 2s, CH=CH). The coupling constant of the styryl protons is 14-15 Hz, indicating trans isomerism at the double bond. It was reported that quinoxalinone was alkylated using dimethyl sulphate to furnish the corresponding N-methyl derivative [10] . In a similar fashion compounds 1a,b were alkylated with dimethyl sulphate in the presence of sodium hydroxide to afford the 6-and 7-benzoyl-1,3-dimethyl-2(1H)quinoxalinones 3a,b, respectively (Scheme 3 In addition, chlorination of 1a with thionyl chloride furnished 6-benzoyl-2-chloro-3-methylquinoxaline (7) (Scheme 4). Its IR spectrum revealed the disappearance of the NH band, present in the parent compound. Also, its mass spectrum showed m/z 267 [M + -15 (CH 3 ), 56.1%]. When the chloro derivative 7 was reacted with sodium azide in ethanol, the 7-benzoyl-4-methyltetrazolo[1,5-a]quinoxaline (8) was obtained which was found to be in tautomeric equlibrium with the 2-azido derivative [11] . Its IR spectrum displayed absorption bands at 1700 (C=O) and the characteristic absorption band for the azido group at 2240 cm -1 [12] . Also, its mass spectrum displayed a molecular ion peak m/z at 289 (M + , 1.6%). Finally, condensation of 7 with n-butylamine in DMF furnished 6-benzoyl-2-butylamino-3-methylquinoxaline (9) . Its IR spectrum showed a NH band at 3250 cm -1 .
Anitmicrobial activities
The antimicrobial activities of the synthesized compounds 1a,b, 2b, 4a,b, 5 and 6b were determined by the agar diffusion technique [13] . The organisms tested were Staphyloccus aureus (NCTC 7447), Bacillus cereus (ATCC-14579), Serratia marcescens (IMRU 70), Proteus merabitis (NCTC-289), Aspergillus ochraceus Wilhelm (AUCC-230) and Penicillium chrysogenum Thom (AUCC-530). The agar media were inoculated with test organisms and a solution of the tested compound in DMSO (250 µg/ml) was placed separately in cups (8 mm diameter) in the agar medium. Streptomycin (25 µg) and mycostatin (30 µg) were used as a reference for the antibacterial and antifungal activities, respectively. The inhibition zones were measured after 24 hr. incubation. The results of the antimicrobial activity tests are summarized in Table 1 . Most of the synthesized compounds were found to possess varied antibacterial activities towards all the microorganisms used with minimal inhibitory concentration (MIC). However, none of the tested compounds showed superior activity than the reference drugs.
Experimental

General
Melting points were determined by an Electrothermal melting point apparatus and are uncorrected. Elemental analyses were carried out by Microanalytical Unit, Faculty of Science, Cairo University. IR spectra were recorded on a Shimadzu 440 spectrophotometer using KBr disks.
1 H NMR spectra were measured on a Varian EM-360 90 MHz spectrophotometer (Varian, UK) using TMS as internal standard. The mass spectra were run by a Shimadzu-GC-MS-GP 100 EX using the direct inlet system.
3-Methyl-2(1H)quinoxalinones (1a,b)
A solution of 4-benzoyl-1,2-phenylenediamine (0.01mol) in acetic acid (50 mL) was treated with a solution of sodium pyruvate (0.01mol) in a minimum amount of water. The reaction mixture was stirred at room temperature for 2 hr and the solid thus obtained was subjected to fractional crystallization to give products 1a,b ( 
6-Benzoyl-3-substituted styryl-2(1H)quinoxalines (2a-c)
A mixture of (1a, 0.01mol), the requisite aldehyde (0.01mol) and piperidine (0.5mL) was fused at 160 o C for 2 hr. The obtained product was crystallized from the appropriate solvent (Table 2) to afford compounds 2a-c. 
6-Benzoyl-3-(4-chlorostyryl)-2(1H)quinoxaline (2a)
IR
6-Benzoyl-3-(4-methoxystryryl)-2-(1H)quinoxaline (2b)
6-Benzoyl or 7-benzoyl-1,3-dimethyl-2(1H)quinoxalines (3a,b)
Dimethyl sulphate (0.022 mol) was added to a solution of (1a or 1b; 0.01 mol) in sodium hydroxide solution (10%, 50 mL). The reaction mixture was stirred at 60 o C for 3 hr and the obtained solid was recrystallized to give (3a,b; Table 2 ). IR spectrum of 3a revealed bands at 2980 (CH-aliphatic) and 1695, 1644 (CO), also 1 
Ethyl [6-or 7-benzoyl-3-methyl-2(1H)quinoxalinon-1-yl]acetate (4a,b)
A mixture of (1a or 1b; 0.01 mol), ethyl chloroacetate (0.01 mol) and potassium carbonate (2 g) in acetone (50 ml) was refluxed for 6 hr. The obtained product was crystallized from the proper solvent to furnish (4a,b; Table 2 ). IR spectrum of 4a: 2982 (CH-aliphatic), 1735, 1680 (C=O). 13 
[6-Benzoyl-3-methyl-2-quinoxalinon-1-yl]acetic acid hydrazide (5)
To a solution of (4a, 0.01mol) in ethanol (50 ml), hydrazine hydrate (0.012 mol) was added. The reaction mixture was refluxed for 10 hr and the obtained product was crystallized from the suitable solvent to yield (5; Table 2 ). Its IR spectrum showed bands at 3300, 3200 (NH, NH 2 ), 1690, 1675 (C=O). Also its mass spectrum showed m/z 336 (1.6%), 321 (15.8%), 305 (84.8%), 277 (5.6%), 264 (5.0%), 249 (100%), 235 (3.1%), 216 (4.5%), 188 (2.2%), 130 (2.3%), 116 (2.3%), 105 (52.4%) and 77 (53.1%).
[6-Benzoyl-3-methyl-2(1H)quinoxalinon-1-yl]acetic acid hydrazones (6a,b)
A solution of the hydrazide derivative 5 (0.01mol) in ethanol (30 mL) was treated with benzaldehyde or p-methoxybenzaldehyde (0.01 mol). The reaction mixture was refluxed for 4 hr and the product that obtained after filtration was crystallized from the proper solvent to afford (6a,b; Table 2 ). IR spectrum of 6a showed bands at 2990 (CH-aliphatic) and 1690, 1670 (C=O). 1 
6-Benzoyl-2-chloro-3-methylquinoxaline (7)
To a solution of 1a, 0.01mol) in dioxane (20 mL) and DMF (5 mL), thionyl chloride (10 mL) was added. The reaction mixture was refluxed for 4 hr and the obtained solid was crystallized from the proper solvent to afford compound 7 ( 
7-Benzoyl-4-methyltetrazolo[1,5-a]quinoxaline (8)
To a solution of 7 (0.01mol) in ethanol (50 mL), sodium azide (0.01 mol) was added and the reaction mixture was refluxed for 6 hr. The product obtained after filtration was crystallized from a suitable solvent to furnish 8 ( 
6-Benzoyl-2-(n-butylamino)-3-methylquinoxaline (9)
A mixture of 7 (0.01mol) and n-butylamine (0.01 mol) in DMF (20 mL) was heated under reflux for 3 hr. After allowing the reaction mixture to cool to room temperature, it was poured into cooled water (100mL). The insoluble material was filtered off and crystallized from the appropriate solvent to give 9 ( Table 1) . Its IR spectrum revealed bands at 3250 (NH), 2995 (CH-aliphatic) and 1688 (C=O). Mass spectrum of 9 exhibited a molecular ion peak at m/z 319 (25%) together with base peak at m/z 105 (100%). 
